Respicardia, Inc. (formerly Cardiac Concepts, Inc.) is a privately held medical device company incorporated in 2006. It is located in Minneapolis, Minnesota, USA. It is developing an implantable system intended to improve the outcomes for Heart Failure patients by developing an implantable stimulation therapy to treat Central Sleep Apnea.
The remedē System is an implantable medical device that is being investigated in a clinical research study for the treatment of Central Sleep Apnea in patients with Heart Failure. It consists of three implantable components:
- remedē Pulse Generator comprised of electronic circuitry components and a battery, which are hermetically sealed in a titanium case
- remedē Stimulation Lead that is implanted in a vein close to one of the phrenic nerves
- a sensing lead to detect respiration Continue reading